Stem Cell Related Stocks Spiking on Reports Obama to Lift 8-Yr Ban on Embryonic Research (STEM, CYTX, PSTI, ASTM, GERN)

February 17, 2009 1:52 PM EST

Any stock related to stem cell research is surging today following rumors that President Obama is expected to issue an executive order lifting an 8-year ban on embryonic stem cell research.

StemCells (Nasdaq: STEM) is leading the group higher, up about 18% from Friday's close. The stock most recently traded at $2.49. Elsewhere in the sector: Cytori Therapeutics (Nasdaq: CYTX) up 10.4% to $4.25, Pluristem Therapeutics (Nasdaq: PSTI) up 14.7% to $1.33 and Aastrom Biosciences (Nasdaq: ASTM) is up 12.6% to $0.58. Meanwhile, recent high-flyer Geron (Nasdaq: GERN) is only modestly higher today, currently up 3.8% to $6.62.


Related Categories

Insiders' Blog
Momentum Movers

Stocks Mentioned

ASTM 0.31

-0.01 -3.13%
Volume: 1,030,404
Track ASTM

CYTX 3.55

+0.05 +1.43%
Volume: 264,233
Track CYTX

GERN 5.48

+0.02 +0.37%
Volume: 999,145
Track GERN

PSTI 1.00

+0.05 +5.26%
Volume: 96,661
Track PSTI

STEM 1.13

-0.01 -0.88%
Volume: 980,958
Track STEM


Add Your Comment